GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | ERBB2 | affects response to substance | EXP | | 6480464 | CTD | ERBB2 affects the susceptibility to arsenite | PMID:31773452 | ERBB2 | decreases expression | EXP | | 6480464 | CTD | arsenite results in decreased expression of ERBB2 mRNA; arsenite results in decreased expression of ERBB2 protein | PMID:31646340 PMID:31934280 | ERBB2 | multiple interactions | EXP | | 6480464 | CTD | [arsenite co-treated with tetrandrine] results in decreased expression of ERBB2 protein; arsenite results in increased expression of and results in increased phosphorylation of ERBB2 protein; ERBB2 affects the reaction [arsenite results in decreased expression of CDH1 protein]; ERBB2 affects the reaction [arsenite results in decreased expression of IL6 protein]; ERBB2 affects the reaction [arsenite results in decreased expression of NDRG1 protein]; ERBB2 affects the reaction [arsenite results in increased expression of CCND1 protein]; ERBB2 affects the reaction [arsenite results in increased expression of PCNA protein]; ERBB2 affects the reaction [arsenite results in increased expression of PTGS2 protein]; ERBB2 affects the reaction [arsenite results in increased secretion of CDH1 protein alternative form]; ERBB2 affects the reaction [arsenite results in increased secretion of EGF protein]; ERBB2 affects the reaction [arsenite results in increased secretion of TGFA protein]; Fulvestrant inhibits the reaction [arsenite results in decreased expression of ERBB2 mRNA] | PMID:31646340 PMID:31773452 PMID:31934280 | |
Go Back to source page | Continue to Ontology report |